Despite major advances in the field of radiotherapy, healthy tissue damage continues to constrain the dose that can be prescribed in cancer therapy. Gold nanoparticles (GNPs) have been proposed as a solution to minimize radiation-associated toxicities by enhancing the radiation dose delivered locally to tumor cells. In the current study, we investigated the application of third-generation GNPs in two-dimensional (2D) and three-dimensional (3D) cell cultures and whether there is synergy between the nanoparticles and kilo-or mega-voltage radiation to cause augmented cytotoxicity. The 10-nm GNPs were found to be nontoxic in both 2D and 3D in vitro cultures of colon cancer cells at concentrations of up to 10-25 mg/ml. There was a significant increase in cell 
selectively induce higher toxicity to tumors than to normal tissue. 5 Specific research interest in GNPs arises from their preferential accumulation in tumors through the enhanced permeability and retention effect, their high surface area to volume ratio as well as their ease of functionalization through thiol functional groups. 4, [6] [7] [8] Research into GNPs in radiotherapy has long demonstrated that the enhancement of radiation dose to cancer cells is possible. 9 However, there are still numerous questions regarding GNPs that have yet to be answered. First, the biocompatibility of GNPs continues to be questioned.
There are publications that suggest that toxicity is dependent on size, 10, 11 shape, 12 surface chemical properties, 13 the particular cell type and model being tested. 14 With so many variables and no common preparation or procedure with which GNPs toxicity can be investigated, the direct comparison of research results is extremely challenging, if not impossible.
Second, the radio-enhancement effect of GNPs may also be dependent on size, 15 energy of radiation, 16 and cell type. 17 The interplay of cell line and radiation energy on radio-enhancement is well illustrated by Jain et al. 16 A statistically significant (40%) reduction in the mean inactivation radiation dose was achieved in MDA-MB-231 breast cancer cells using 160 kVp x-rays. However, no significant reduction was observed in DU145 human prostate cancer cells or L132 lung epithelial cells despite confirmation of GNP uptake. Moreover, increasing the energy of the radiation to 6 MV led to 29% reduction in mean inactivation dose in MDA-
MB-231 cells but in DU145 cells, only a 13% reduction was observed.
This shows that even identical experimental protocols by the same research group yields results that display no obvious trend or tendencies.
Despite these difficulties, GNPs demonstrate great potential in radiotherapy and cancer treatment. Further research and innovations in this field will enable the eventual establishment of the true effectiveness of GNPs in radiotherapy.
Here, we report the results of an investigation into the biocompatibility as well as the synergy between GNPs and ionising radiation. We demonstrated the potential of GNPs to increase cell death. Specifically, we evaluated the in vitro toxicity of our GNP formulation in LOVO human colon cancer cells in both a two-dimensional (2D) culture and three-dimensional (3D) model. The radiation enhancement and synergistic effects with both 50-kVp x-ray and 6-MV photon radiation were determined using the clonogenic assay.
| M AT E RI ALS A ND ME TH OD

| GNPs synthesis
The GNPs were synthesized by reduction of auric chloride using a method previously outlined. 18 In brief, tetrakis (hydroxymethyl) phosphonium chloride (80%) was added into an alkaline solution while stirring, followed by the addition of gold (III) chloride trihydrate. This turns the mixture from a yellow to a dark brown color, indicating the formation of the GNPs. The GNPs were then used as is as non-polyethylene The surface charge (f-potential) of the nGNPs and the pGNPs were determined using a Zetasizer Nano ZS (Malvern Instruments, Worcestershire, U.K.). Samples were tested at room temperature (258C) with a refractive index of 1.
| Dynamic light scattering
The size of the nGNPs and the pGNPs were determined using a Zetasizer Nano ZS (Malvern Instruments). Samples were tested at room temperature (258C) with a refractive index of 1. The mass median diameter was reported.
| Atomic force microscopy
Atomic force microscopy (AFM) on nGNPs and pGNPs were conducted in tapping mode using a NanoIR (Anasys Instruments, CA). The particles were fixed onto a mica disk by poly-lysine in order to be imaged.
| Scanning transmission electron microscopy
Scanning transmission electron microscopy (STEM) was performed using a Carl Zeiss Ultra Plus Field Emission Gun SEM. Copper 100 mesh STEM grids with formvar film (Proscitech, Australia) were dipped into a small drop of each GNP solution. The grid was quickly retracted and allowed to dry. The images were taken at an acceleration voltage of 30 kV using a STEM detector. 
| In vitro investigations
| 3D cell migration assay
The ring closure assay was carried out as per the protocol previously reported in the literature. 19 Briefly, LOVO cells incubated with Nanoshuttle V R were levitated with neodymium magnets overnight to form aggregated 3D clusters, which were then dispersed using a pipette. A cell density of 2 3 10 5 cells per well was seeded to an ultralow attachment 96-well plate placed on top of a 96-well ring-shaped magnetic drive. Cells were incubated for 1 hr to form a robust 3D ring structure.
pGNPs (10, 25, 50 , and 100 mg/ml) were added to respective wells with n 5 3 per concentration. The cell rings were monitored using a mobile device (Ipod Touch, Apple computer) with a specific application (Experimental assistant, n3D Biosciences) that takes images at 15 min intervals. The images were analyzed using a custom n3D software image analysis code written in MATLAB (Matworks, Natick, MA) to measure the outer diameters of the ring. The percentage change in diameter was assessed by normalizing the diameters to its initial diameter. Phase images of the cell rings at each concentration were taken after 24 hr using a Nikon Eclipse TE2000-U inverted fluorescent microscope.
| 3D spheroid assay
The assay was carried out as previously outline. 20 Briefly, the Nano- To minimize stress on the cells, no antibiotics or antifungal agents were used in these experiments. 21 Once 80% confluent, the growth medium was discarded and the adherent cells were washed with PBS (Gibco Life Technologies) twice. Cells were then detached using .05%
trypsin-EDTA solution for 4-6 min at 378C as previously described. 22 The detached cells were centrifuged at 252 3 g for 5 min at room temperature. The cells were then plated in T25 cm 2 flasks (Corning, MA) at a density of 1,500 cells in 5-ml growth medium.
| Kilo-voltage radiation dose determination
Twenty four hours after plating, each flask was supplemented with 20 ml of media. Irradiation was carried out a further 24 hr later on a Pantak Orthovoltage Unit using a 50-kVp beam to a uniform dose of 1
Gy. For all experiments, unexposed controls (0 Gy) were prepared as sham exposures.
| Mega-voltage radiation dose determination
Twenty four hours after plating, each flask was supplemented with 20 ml of media. Irradiation was carried out a further 24 hr later on a
Varian Novalis TX linear accelerator with a 6-MV photon beam at a dose rate of 6 Gy/min. To achieve full scatter conditions, flasks containing the cells were placed in a custom built Perspex phantom that accommodates T25 flasks. The phantom was placed between slabs of solid water to locate the cell layer at a depth of 50 mm when irradiated at gantry 1808 as previously described. 23 The cells were irradiated to a uniform dose of 2 Gy. For all experiments, unexposed controls (0 Gy)
were prepared as sham exposures.
| GNP concentration determination
Twenty four hours after plating, each flask was supplemented with 20 ml of media modified with different concentrations of pGNPs (2, 4, 5, 10, 25, and 50 mg/ml) and further incubated for 24 hr.
| Investigation of synergistic effect of GNPs and radiation by clonogenic assay
Twenty four hours after plating, the media was replaced with 20 ml of new media or new media modified with addition of 50 mg/ml of pGNPs for the treated culture and incubated for 24 hr. The cells were then irradiated in air with either 2 Gy of 6-MV x-ray or 1 Gy of 50-kVp x-ray as outlined above.
| Clonogenic survival assay
Following the above treatment/s, all flasks were incubated at 378C for 10 days until colonies of greater than 50 cells formed, then were fixed and stained with .4% crystal violet (Sigma-Aldrich, MO). The number of colonies were counted using ColCount colony counter (Oxford Optronix, U.K.). All experiments were carried out in triplicate and on three separate occasions.
| Statistics
Statistically significant differences were determined with Prism 6 (GraphPad Softrware, CA) by one-tailed unpaired t test or one-way analysis of variance (ANOVA) with a p value of .05 or less considered significant. 
| GNP characterization
Both the nGNP and pGNP were tested using electrophoretic light scattering to determine their f-potential. The size measurements of nGNP and pGNPs were carried out using dynamic light scattering, AFM, and STEM.
The f-potential and the size of the GNPs increased by 27.9 mV and 3.3 nm, respectively, after the PEGylation process (Table 1 ). To analyze further the effect of pGNPs on cells, LOVO cells were also magnetically manipulated to form 3D spheroid structures and exposed to different concentrations of pGNPs over 24 hr. The change in area of the spheroid was monitored to assess cell toxicity. Changes to spheroids were apparent over the 24-hr period (Figures 4a and 4b) .
As per the ring assay, quantitative analysis indicates a statistically significant (One-way ANOVA multiple comparisons) difference in the reduction of the spheroid size at 50 mg/ml (p < .0045) and 100 mg/ml (p < .0001) when compared to control (Figure 4c ). The phase images of the spheroids before and after 24-hr incubation are shown in Figure 4d .
| GNP potentiation of radiation dose
The LOVO cell survival fractions at different doses of kilo-and mega- 
| D I S C U S S IO N
The change in f-potential after the PEGylation process confirms that the PEG molecules are grafted on to the GNPs surface. This is further confirmed by the increase in size of the GNPs after PEGylation, as determined by electrophoretic light scattering. AFM images also revealed an overall increase in the particle size. Combined, both techniques along with STEM suggest that the particles were approximately 10 nm after PEGylation. A particle size of 10 nm was considered favorable, as we hypothesize that smaller GNPs would maximize the potential of secondary electrons to escape the nanoparticles, thereby maximizing the damage to tumor cells. Also, while compared to particles of 1-2 nm, 15-nm GNPs have been found to be comparatively nontoxic. 10 Therefore, 10-nm GNPs were proposed to be the optimal size and were used in further experiments.
The importance of PEG in stabilizing the GNP is highlighted by literature incubate the cells with GNPs for only 24-72 hr. 10, 16, [24] [25] [26] This suggests that the toxicity profile of GNPs can change over time at different concentrations. We speculate that this is due to increasing uptake of GNPs as exposure time increases. It has been reported that both 5-and 15-nm GNPs continue to be taken up by Balb/3T3 mouse fibroblasts for up to at least 72 hr. 27 In addition, the accumulation of GNPs in cell lysosomes has been found to impair lysosome degradation capacity, ultimately affecting cellular homeostasis. 28 Therefore, we propose that increased uptake of GNPs by prolonged incubation time has a cumulative negative effect on cellular homeostasis, leading to retarded cell proliferation at higher concentrations over time.
The viability of the cells does not seem to change with increasing pGNPs as suggested by the Live/Dead assay. However, as in the phase contrast image there is an obvious decrease in the confluence of the cells, especially at 50 mg/ml. Given that we see a decrease in proliferation but no change in viability, it may be possible that the dead cells detached during the washing process of the assay. This would lead to healthy green cells being apparent in the assay, while the absolute number of cells decreases.
Alternatively, the cells may sense that there is a "toxin" in its environment, which leads to slower proliferation and migration toward other cells to form tight clusters to minimize exposed surface area and toxicity.
The growth of cells was also evaluated using 3D cell models, which more accurately portrays the actual biochemical environment of the cells in vivo than traditional 2D cell culture. 19 The toxicity of specific compounds has been found to be different in the two culture types, with 3D models often being more resilient than 2D models. 19, 29 Therefore, for the current study, the maximum pGNP concentration was increased from 50 to 100 mg/ml to assess the difference, if any, of the two culture types in their response to pGNPs.
In the 3D ring closure and spheroid assay, the general trend of ring size reduction for 25 mg/ml follows more closely to that of the lower 10 mg/ml as oppose to the 50 mg/ml observed in the 2D culture (Figures 3c and 4c) . This supports the trend that cells in 3D cultures tends to be more resilient than in 2D culture.
The contraction of the ring size was significantly higher at both 50 and 100 mg/ml when compared to the lower concentrations. This was a surprising result as it was previously stated that toxic compounds should cause the spheroid to contract at a slow rate. 20 Variability in response to toxicity has been found to arise from differences in the extracellular matrix composition as well as cell to extracellular matrix interactions. 19 Therefore, it is possible that the LOVO cells actually contract at a higher rate in response to toxicity, which corresponds exactly to their behavior of contraction/clustering to form smaller colonies in the 2D culture. This argument is further supported by the closing of the internal gap of the ring (Figure 3d ), which is akin to a 3D wound healing assay. 19 At up to 50 mg/ml, the cells were able to migrate quickly to completely close the gap of the ring after 24 hr.
Even at 100 mg/ml, only very sparse gaps are observed. The same trend again is found in the spheroid assay, with statistically significant reduction of spheroid size for both 50 and 100 mg/ml (Figure 4c ). Both contraction of the ring and the spheroid, coupled with the migration of the cells through the inner gap of the ring can be seen as the cell's While it is common to use treatment doses that cause a 50% reduction in survival fraction, this was deemed inappropriate in the current study. At 50% survival from radiation alone, the combination of radiation and pGNPs would leave little room for establishing additional toxicity from any synergy effect that may take place. Therefore, a less cytotoxic dose of 1 Gy was utilized for the combination study, which produced a survival fraction of .79. In combination with pGNPs, this dose was considered most likely to reduce survival fraction to approximately 50%.
The survival fraction of LOVO cells for the same dose was higher when exposed to mega-voltage radiation than when exposed to kilovoltage radiation (Figure 5b ). This is expected in view of the higher linear energy transfer of the kilo-voltage beam relative to the megavoltage beam. 30 In keeping with the aim of achieving a combined 50% reduction in survival, 2 Gy of mega-voltage radiation was selected, having lowered the survival fraction to .72.
In the pGNP concentration range of 0 to 50 mg/ml, the cells did not exhibit a linear dose response (Figure 5c ). Rather, the toxicity appears to be stepwise. The literature on nanoparticle toxicity appears to have conflicting findings. Numerous studies have concluded that no toxicity was observed from their GNP preparation, 25, 31 while others have found otherwise. 24, 32 In our study, we observed a small increase in the survival fraction of cell treated with low concentration of pGNPs, which has not been supported by any previous findings. Further studies are required to explain this phenomenon.
As an initial investigation, the maximum concentration was chosen so as to maximize the potential of the pGNPs to increase the radiation dose while incurring tolerable toxicity. Therefore, 50 mg/ml was selected for further studies.
The statistically significant further reduction in survival fraction in both irradiation energies when treated with pGNP indicates that there is synergy between radiation and pGNPs. While direct comparison of research is difficult, similar levels of enhancement has been achieved previously with mice colorectal adenocarcinoma CT26 cells using smaller GNPs (6.1 nm) and the same radiation energies. 7 An approximately 20-35% local enhancement of radiation dose potentially translates to a worthwhile contribution to radiotherapy treatment.
Following this initial study, it would be necessary to gain knowledge of the localization and the aggregation behavior of the GNPs in the cells. It is likely that the aggregation characteristics within cells would largely affect both the toxicity and dose enhancement potential of the GNPs. Therefore, this knowledge would be essential in discovering why enhancement and toxicity appear to differ between cells as well as how to maximize the synergy between radiation and GNPs.
We are currently performing modeling studies to evaluate the effect of aggregation on dose enhancement.
| C O N C L U S I O N S
We have shown that our PEGylated GNP (pGNP) formulation is nontoxic in LOVO cells up to concentrations of 10 mg/ml. Concentrations of 25 and 50 mg/ml were able to lower cell proliferation in 2D culture.
Similar to previous studies, the cells grown in 3D cultures were more resilient, with toxicity observed only at 50 and 100 mg/ml. Interestingly, the cells appear to contract and cluster together in the presence of toxins, which we propose to be a defensive mechanism of the cells to minimize exposure. Ultimately, we demonstrated synergistic effects of pGNPs with both kilo-voltage and mega-voltage radiation in LOVO colon cancer cells. We achieved approximately 20-35% increase in cytotoxicity from x-rays, which suggest great potential for the use of GNPs in radiotherapy.
